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Abstract In an effort to study the nature of tubulin attachment 
to membranes, we have previously observed that after blocking 
prenylation in FRTL-5 thyroid cells, the microtubules become 
disconnected from the plasma membrane region [Bifulco M. et al. 
(1983) J. Cell. Physiol. 155, 340-348]. In this study we show that 
several |3H]mevalonate labeled proteins in FRTL-5 cells 
associate with membrane and cytoskeleton and, among these, 
we describe the presence of a 48-kDa prenylated protein, 
identified by immunoprecipitation as 2',3'-cyclic nucleotide 
3'-phosphodiesterase (CNP), that associates with microtubules. 
This latter association persists through several polymerization/ 
depolymerization cycles, whereas other prenylated proteins are 
lost. It is suggested that CNP can be a novel microtubule-
associated protein (MAP) and a promising candidate as a 
membrane anchor for microtubules. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The cytoskeleton is involved in numerous cellular functions 
such as secretion, shape changes and migration, ingestion in 
simple eukaryotes, mitosis and cytokinesis, and cell-cell con-
tacts. In many cases these functions require anchorage of the 
cytoskeleton to the membrane. This could occur by direct 
insertion of the microtubules into the membrane, by associa-
tion of microtubules with an intrinsic membrane protein, or 
association of microtubules to the plasma membrane through 
a linker protein. While the mechanisms for such interactions 
are known for actin microfilaments, the details of microtu-
bule-membrane interactions are less clear [1^4]. Ample cyto-
logical evidence exists for lateral and end-on microtubule con-
tacts with plasma and other cellular membranes [5-7]. In some 
cases contacts appear to be very close, whereas in others, a 
clear-cut space between microtubules and membranes can be 
observed containing bridges or linkers that appear to attach 
the two structures. It is reasonable to suppose that these 
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bridges contain connector proteins attached at one end to 
microtubules and at the other to the membrane or the mem-
brane cytoskeleton as occurs with actin fibers and its linkers. 
Dyneins and kinesins connect intracellular membranes with 
microtubules, but few, if any, linker proteins to cellular mem-
branes have been identified and the nature of the forces lead-
ing to attachment is not known. 
A possible clue was provided in a recent study [8], wherein 
it was shown that after blocking prenylation of proteins with 
lovastatin in FRTL-5 thyroid cells, microtubules become dis-
connected from the plasma membrane region and retract to-
wards the cytosol. Because prenylation often facilitates pro-
tein attachment or translocation to the membrane [9-11], we 
reasoned that prenylation might be involved in the attachment 
of microtubules to the cell periphery or membrane. Because 
tubulin does not contain the carboxyl-terminal 'CaaX' (cys-
aliphatic-aliphatic-any amino acid) sequence motif required 
for prenylation, this would presumably have to be mediated 
by a prenylated linker protein that does. In the present study 
we describe the presence of a 48-kDa prenylated protein in 
FRTL-5 cells that associates with membranes and microtu-
bules, and that it is the well known enzyme 2',3'-cyclic nucleo-
tide 3'-phosphodiesterase (E.C.3.1.4.37) or CNP. 
2. Materials and methods 
2.1. Cells 
FRTL-5 cells (ATCC CRL-8305) are a strain of rat thyroid cells, 
cloned and characterized in our laboratory by Dr. F.S. Ambesi-Im-
piombato, whose characteristic and culture conditions have been ex-
tensively described [8,12]. They were grown in Coon's modified Ham's 
F-12 medium supplemented with 5% calf serum and a six-hormone 
mixture of thyrotropin, insulin, hydrocortisone, transferrin, somato-
statin, and glycil-L-histidyl-L-lysine acetate. This mixture will be re-
ferred as 6H. C6 Glioma cells were obtained from the American Type 
Culture Collection (Rockville, MD) and grown in Dulbecco's modi-
fied Eagle's medium (DMEM) supplemented with 10% fetal calf se-
rum. 
2.2. Materials 
Lovastatin was a gift from Dr. Alberts of the Merck, Sharp and 
Dohme Inst. Taxol was provided by the National Cancer Institute, 
USA. (RS)-[5-3H]Mevalonate (MVA) (35.0 Ci/mmol) was from NEN 
DuPont. The rabbit autoantibody against CNP1 was a generous gift 
from Dr. D. Jacobowitz, NCI Bethesda Md, USA [13]. Rat brain 
microtubule protein was prepared by sequential polymerization as 
previously described [14]. 
2.3. [''HJMevalonate labeling of prenylated proteins 
FRTL-5 cells were preincubated with 10 u.M lovastatin for 5 h, 
washed, and incubated with 30 u,Ci/ml [5-3H]mevalonate for 16 h. 
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Cells were then washed 3 times in PBS, scraped from the dish and 
lysed in hypotonic buffer. Equal amounts of each protein extract were 
analysed by 12% sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) as described [15,16]. 
2.4. Cell fractionation 
Total cellular homogenate was centrifuged at lOOOOOXg at 4°C for 
1 h to obtain a supernatant (SI00) and a pellet (PI00) fraction. 
Cells were extracted at room temperature with 1% (v/v) Triton 
X-100 in a microtubule-stabilizing buffer (0.1 M Pipes, 1 mM MgCi2, 
2 M glycerol, 2 mM EGTA, 1 mM PMSF and ImM DTT, pH 6.9) to 
obtain a detergent soluble (SOL) and an insoluble cytoskeletal frac-
tion (CSK) as described [17]. 
2.5. Microtubule purification 
2.5.1. Taxol procedure. FRTL-5 cells labeled with [3H]MVA were 
scraped from the washed dishes, collected and centrifuged at 4°C, 
2000 rpm resuspended in 0.1 M Pipes, 1 mM EGTA, 1 mM MgCl2, 
1 mM PMSF, pH 6.6 and homogenized and processed with 20 uM 
taxol as described in [18]. 
2.5.2. Copolymerization with carrier brain microtubule protein. To-
tal cellular lysate from [3H]MVA-labeled FRTL-5 cells was mixed 
with unlabeled rat brain microtubule protein [19] and carried through 
cycles of temperature-dependent polymerization/ depolymerization 
[18]. In each cycle the microtubule pellets were analyzed by 12% 
SDS-PAGE. The gels were fluorographed or sliced into 2-mm sec-
tions, and the distribution of the major proteins-associated radioac-
tivity was determined by scintillation counting following digestion of 
each slice as previously described [19]. 
2.6. Immunoprecipitation and SDS-PAGE 
[3H]MVA labeled third cycle of polymerization, obtained from la-
beled FRTL-5 cell homogenate mixed with rat brain microtubule 
protein as described before, was solubilized in RIPA buffer [20 mM 
Tris, 150 mM NaCl, 1 mM EDTA, 0.5% (v/v) Nonidet P40, 0.5% 
(w/v) Na deoxycholate, 0.1% (w/v) SDS, 1% (v/v) Trasylol, 0.2 mM 
PMSF, pH 7.4] and immunoprecipitated with preimmune rabbit se-
rum or rabbit autoantibody against CNP1 at 4°C for 18 h, followed 
by incubation with Protein A-Sepharose (Pharmacia). Immunopreci-
pitates were washed five times with RIPA buffer and then dissolved in 
Laemmli loading buffer with 1 mM DTT prior to be electrophoresed 
in a 12% SDS-PAGE [20]. Gels were then permeated with Amplify 
fluorographic enhancer (Amity), dried and autoradiographed at 
-80°C. 
2.7. Total RNA preparation and Northern blot analysis 
Total cellular RNA was extracted by the guanidinium thiocyanate-
acid phenol procedure and quantitated by spectrophotometry as pre-
viously described [21]. Twenty micrograms of total RNA from each 
cell strain were loaded and separated on 1% agarose gels containing 
2% formaldehyde and blotted onto nylon membranes (Hybond-N 
Amersham). Prehybridization (1 h at 65°C), hybridization (16-18 h 
at 65°C) and high stringency washes (15 min at 37°C, 1 h at 60°C, 1 h 
at 55°C) were carried out as already reported [21]. The cDNA, 
pCNP7 (kindly provided by Dr. Braun and De Angelis, Montreal, 
Canada) was used as radiolabeled probe [22]. Normalization was ac-
complished using radiolabeled glyceraldehyde-phosphate dehydrogen-
ase (GAPDH) cDNA (kindly provided by Dr. V.E. Awedimento, 
Napoli, Italy) as reference probe. 
2.8. Other assays 
Protein concentration was determined using a Bio-Rad kit; recrys-
tallized bovine serum albumin was the standard. 
bers of the Ras family. Prominent bands also occur at ap-
proximately 48 and 56 kDa (Fig. 1). We investigated the as-
sociation of these prenylated bands with membrane and 
cytoskeletal fractions. Homogenates from [3H]MVA-labeled 
FRTL-5 cells were partitioned into a lOOOOOXg pellet 
(P100) and supernatant solution (S100). This revealed similar 
distributions of the p21 group and 48-kDa prenylated pro-
teins, whereas the 56-kDa protein was found primarily in 
the supernatant fraction (Fig. 1). Extraction of the whole 
homogenate with 1% Triton in a microtubule stabilizing buff-
er yielded a soluble and insoluble cytoskeleton fraction whose 
prenylated proteins resembled, respectively, that of SI00 and 
P100 fractions (Fig. 1). 
3.2. 48-kDa prenylated protein association with microtubules 
Attempts were made to determine if any of the prenylated 
proteins might associate with tubulin or microtubules. We 
purified microtubules from homogenates of [3H]MVA-labeled 
FRTL-5 cells by repeated cycles of polymerization/depolym-
erization in the presence of 20 uM taxol [18]. In this proce-
dure a microtubule-associated protein (MAP) is defined as 
copolymerizing with microtubules through several such cycles. 
As shown in Fig. 2A, the overall specific activity (3H/ug pro-
tein) decreased to an approximately constant level, indicating 
a stoichiometric relation between a labeled protein and tubu-
lin. This suggests that some label proteins remained with the 
microtubule pellet, whereas most other proteins were lost dur-
ing repeated cycles of polymerization [19]. If prenylated pro-
teins behave like MAPS, they should co-cycle with brain mi-
3. Results 
3.1. [sHJMVA-labeled proteins in FRTL-5 cells 
When quiescent control FRTL-5 cells (NoH, i.e. cells main-
tained for 72 h in a medium from which the hormone supple-
ment was removed) are labeled with [3H]MVA for 24 h in the 
presence of 10 uM lovastatin to prevent dilution of the label 
by endogenous mevalonate, about 12 labeled bands can be 
identified on a 10% SDS gel. Six of these are in the low 
molecular weight range here labeled p21, which contain mem-
Fig. 1. Pattern of [3H]MVA-labeled proteins in total cellular lysate, 
S-100 and P-100 fractions, cytoskeleton (CSK) and soluble (SOL) 
fractions from FRTL-5 thyroid cells. Cells were preincubated with 
10 uM lovastatin for 5 h, washed, incubated with 30 uCi 
5-[3H]MVA for 16 h and then processed as described in Section 2. 
A portion of each fraction (90 |ig of proteins) was subjected to elec-
trophoresis on a 12% SDS-polyacrylamide gel. Molecular weight 
standards are shown on the right (in kDa). The autoradiogram was 
exposed for 15 days. 
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Fig. 2. Purification of microtubules from FRTL-5 cells. (A) [3H]MVA-labeled proteins from FRTL-5 cells were processed as for the isolation, 
by taxol procedure, of tubulin and microtubule-associated proteins. An aliquot of each fraction was measured for radioactivity and protein 
content, and results are expressed as dpm/u,g total protein. H, homogenate; LS, low speed supernatant; HS, high speed supernatant; numbers 
1 and 2 refer to polymerization cycles. Bars represent the average of triplicate experiments. (B) and (C) Copolymerization of [3H]MVA labeled 
proteins from FRTL-5 cells with carrier rat brain microtubule protein. Total cellular lysates prepared from [3H]MVA labeled cells were mixed 
with unlabeled rat brain microtubule protein (MTP, 18 mg/ml) and carried through several cycles of polymerization/depolymerization. Equal 
amounts of proteins (50 u,g) were analyzed by 12% SDS-PAGE. (B) The percent of the radioactivity in gel slices of the major bands, 48-kDa 
and 21-kDa group, which contains members of the Ras family, is listed as a fraction of the total counts applied. The insert show the Coomas-
sie stained tubulin (a) and the corresponding autoradiograph (b) from the third cycle of polymerization. (C) Autoradiograph of the pattern of 
the [3H]MVA-labeled proteins obtained from four consecutive copolymerization cycles, depicted in panel B, exposed for 20 days. Molecular 
weight standards are shown on the left. These data are representative of three independent experiments. 
Fig. 3. Expression and immunoreactivity of CNP in FRTL-5 cells. (A) Northern blot analysis of CNPl mRNA expression in FRTL-5 and C6 
cells. Twenty micrograms of total RNA were used in each lane. Top panel, the blot was probed with a CNPl cDNA. Bottom panel, the blot 
was stripped and reprobed with a rat glyceraldehyde phosphate dehydrogenase (GAPDH) cDNA probe, performed as a control that similar 
amounts of RNA were loaded in each lane. The positions for 28S and 18S are indicated on the right. (B) Immunoprecipitation of the 
[3H]MVA-labeled 48-kDa protein present in the third cycle of polymeryzation, obtained from labeled FRTL-5 cell homogenate mixed with un-
labeled rat brain microtubule protein as described in Fig. 2, with an anti-CNPl antibody. The immunoprecipitates were subjected to SDS-
PAGE. Lanes: 1, rabbit preimmune serum; 2, rabbit anti-CNPl antibody. Molecular weight standards are shown on the right. Autoradiogram 
was exposed for 30 days. These data are representative of two independent experiments. 
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crotubule proteins. To test it, [3H]MVA-labeled FRTL-5 cell 
homogenate was mixed with unlabeled rat brain microtubule 
protein and repeatedly carried through five cycles of polymer-
ization, in absence of taxol. As shown in Fig. 2B and C, the 
3H associated with the 48-kDa protein present in the micro-
tubule increased progressively, as measured in 12% SDS gels, 
with each successive cycle of polymerization until the fifth 
cycle, whereas the p21 proteins decreased progressively and 
became undetectable after the third one. In the third and 
fourth polymerization/depolymerization cycles (Fig. 2C), 
while there was loss of protein, 48-kDa band was the only 
labeled protein remaining. This suggests that the 48-kDa pro-
tein behaves like a MAP, showing a significant association 
with tubulin [19]. 
3.3. Identity of 48-kDa protein as 2',3'-cyclic nucleotide 
3' -phosphodiesterase 
The association of the 48-kDa prenylated protein with the 
particulate/membrane fraction on the one hand, and with mi-
crotubules on the other, led to attempts at identification of 
this protein. On the basis of prenylation and its gel molecular 
mass, it seemed possible that it might be 2',3'-cyclic nucleo-
tide 3'-phosphodiesterase (CNP), a prenylated and palmitoyl-
ated enzyme of uncertain function in the cell that was first 
described in the liver, but is most abundant in neural tissue 
[20,23-26]. It is a plasma membrane-associated protein which 
has previously been suggested to be related in an unspecified 
manner to the cytoskeleton [17,27-29]. There are two iso-
forms, CNP1 and CNP2 (46 and 48 kDa), resulting from 
alternative splicing [25]. In the rat CNP1 is larger in size 
( ~ 4 8 kDa) and substantially more abundant than CNP2 
[13,30]. However, FRTL-5 cells express significant levels of 
mRNA for CNP1 in comparison to those present in C6 glio-
ma cells (Fig. 3A), that possess a relatively high rate of CNP 
synthesis [20]. 
Finally we confirmed the hypothesis that the 48-kDa pre-
nylated protein could be the CNP1 by an immunoprecipita-
tion experiment [20]. The [3H]MVA-labeled 48-kDa protein 
comigrating with CNP1, present in the third cycle of polymer-
ization, obtained from labeled FRTL-5 cell homogenate 
mixed with unlabeled rat brain microtubule protein and proc-
essed as described above, was specifically immunoprecipitated 
with a rabbit anti-CNPl antibody (Fig. 3B). 
4. Discussion 
In this study we describe the presence of a 48-kDa prenyl-
ated protein in FRTL-5 cells that has the characteristics of 
CNP. On the basis of the reaction with an antibody that 
recognizes exclusively CNP1, and the larger size of rat 
CNP1, we believe that the 48-kDa protein labeled with 
[3H]mevalonate in these rat thyroid cells is CNP1. Moreover, 
FRTL-5 thyroid cells express significant levels of CNP1 
mRNA. Like many other proteins whose residence in the 
plasma membrane is determined by post-translational lipid 
modifications, the partition of CNP between membrane and 
cytoplasm has been ascribed to isoprenoid modification [20]. 
CNP is modified by both types of prenyl groups, farnesyl and 
geranylgeranyl [31], and it is also palmitoylated [26]. More-
over, CNP has an isoelectric point > 9 [13,25] which could 
favor interaction with acidic regions in the membrane or mi-
crotubule, although there is no distinct polybasic domain. The 
prerequisites for association with both membranes and micro-
tubules are, therefore, present in CNP. 
We show evidences that CNP associates with microtubules 
in FRTL-5 cells. Our findings in no way rule out CNP inter-
actions with other proteins of cytoskeleton. In fact, it has been 
recently reported that CNP binds to actin-based cytoskeletal 
elements [29]. However CNP, according to our data, behaves 
like a MAP, showing a significant association with tubulin. 
Colocalization of CNP and tubulin has also been previously 
investigated in oligodendroglial membrane sheets [28]. The 
precise nature of the association of CNP with microtubules 
and membrane remains to be determined. The prenylated 
CNP can be the target of lovastatin effect in severing the 
connection between microtubules and the plasma membrane. 
Thus CNP can represent an anchor protein involved in the 
attachment of microtubules to the membrane. 
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